Donate
T1International’s Impact in 2024

T1International’s Impact in 2024

Facebook Google LinkedIn Twitter

“Small acts, when multiplied by millions of people… can transform the world.”

Lately, I’ve been thinking a lot about this quote from Howard Zinn. It is a way for me to keep hope in uncertain times, and remember the power of collective impact and community.

I am certainly grateful for the global type 1 diabetes community. I always feel a keen kinship with people living with diabetes like me, those who inherently understand the daily struggles of living with this disease and the imperative to fight for access to the medications and supplies that allow us to live. It is the main reason I was so excited when I first learned about T1International— an organization by people with diabetes, for people with diabetes, focused on harnessing our collective power to make the changes we need to survive. Over the past five years on my journey from local Chapter member to chair of the Board of Trustees, I’ve been as thankful for the community of advocates leading the way as I have been proud of what we’ve accomplished together. And boy, am I proud.

T1International’s annual report demonstrates the breadth of the impact that is possible when individual patient advocates are given the infrastructure and support they need to make big change. I was inspired by our Chapter in Gaza advocating for urgent medical aid; galvanized by our Partners in Sierra Leone that established a diabetes care unit in a local hospital; and awed by our Partners in Pakistan’s accomplishments around locally manufacturing insulin.

But overall, I was humbled by our commitment to our values. All of these efforts were patient-led. T1International’s independence allowed for actions like Washington’s protest against a major insulin company. The transparency of our organization is evidenced by its sharing of how funds are collected and spent. Our network is inclusive of people with diabetes from all walks of life, all over the world. The steps we’ve taken together have been bold, and they leave me feeling hopeful.

Last month, I was fortunate enough to join fellow advocates in Washington, DC to meet with United States legislators about the changes needed to make #insulin4all a reality in America. Telling our stories, providing solutions, and partnering with elected officials was a powerful reminder of what is possible when we work together. I left with a renewed hope for the work ahead and commitment to ensuring that people like me throughout the world can live without the fear of how we’ll access our insulin.

I hope you’ll join me in this commitment. In a time when the work of nonprofits like T1International is increasingly needed yet increasingly under attack, you are needed more than ever. So please: read the report, connect with a local chapter, donate what you can. After all, these small acts, when we come together as a global community, can transform the world.


Melissa Passarelli is the Chair of T1International’s Board of Trustees and a person living with type 1 diabetes.

Related posts:

T1International Year in Review: 2024

T1International Year in Review: 2024

As 2024 comes to an end, we’re taking a moment to reflect on the collective power of the T1International community. This year has been filled with challenges and victories as we’ve worked together to fight for affordable and accessible insulin. Here’s a month-by-month look at what we’ve accomplished, thanks to your support and the dedication of advocates across the globe. Read more

Make it Right: The Fight for Insulin Access on World Diabetes Day

Make it Right: The Fight for Insulin Access on World Diabetes Day

On World Diabetes Day, we shine a spotlight on a glaring injustice: millions of people with diabetes in low- and middle-income countries are denied access to affordable insulin pens—a delivery method that could save and transform lives. Pharmaceutical giants Eli Lilly, Novo Nordisk, and Sanofi have monopolized the diabetes market, prioritizing profit over people. It’s time to demand change. It’s time to make it right. Read more

T1International Announces Leadership Transition: Shaina Kasper Named Executive Director

T1International Announces Leadership Transition: Shaina Kasper Named Executive Director

T1International is pleased to announce that Shaina Kasper has been appointed as the new Executive Director. Shaina succeeds Elizabeth “Liz” Pfiester, the organization’s Founder and Executive Director since 2013, who established T1International as a force for change in the fight against insulin price gouging and for the rights of people living with type 1 diabetes. Read more

Global Advocacy Success Series: Kelia Moses, WE Care Sierra Leone

Global Advocacy Success Series: Kelia Moses, WE Care Sierra Leone

The idea to work on this issue stemmed from a personal experience that deeply impacted me. In 2008, I lost my aunt to diabetes-related complications. Witnessing her struggle with diabetes and the lack of medical expertise to detect and manage her condition was a profound and heartbreaking experience for me. Read more

The movement for public insulin production continues to grow in the United States

The movement for public insulin production continues to grow in the United States

This blog post was first published in Bridge Michigan on May 28, 2024 by Quinn Nichols, Nicole Koonce, and Allison Hardt under the title: Michigan has a chance to learn from California’s public pharma initiative. Read more

Open letter to WHO calling for urgent action on meaningful patient engagement

Open letter to WHO calling for urgent action on meaningful patient engagement

We are writing to propose WHO action items aimed at addressing meaningful engagement with people living with diabetes in the global coverage targets for diabetes. Read more

T1International Invited to White House Event

T1International Invited to White House Event

T1International advocates, Jesús Morales Sánchez (Communities of Color Working Group Co-Leader), Kristen Whitney Daniels (Federal Working Group Co-Leader), Lib Gatti (USA Advocacy Manager), and Shaina Kasper (Policy and Advocacy Director), were honored to be invited to a recent event at the White House focused on lowering healthcare costs. The event celebrated the success of the access to medicines movement in achieving a $35 monthly cap on out-of-pocket costs for insulin for Medicare Part D beneficiaries, allowing Medicare to negotiate drug prices directly with pharmaceutical companies, and more. Read more

A Note from T1International’s New Board Chair about T1International’s Impact

A Note from T1International’s New Board Chair about T1International’s Impact

As a person living with type 1 diabetes who has been involved with T1International since 2019, I’m so proud to step into the role of Board Chair of Trustees this year. I believe in this organisation and this cause deeply because it is personal to me. I live with the ups and downs of diabetes, and I believe in health justice for everyone who is faced with this condition worldwide. Read more

Levemir Discontinuation Impacts Patients

Levemir Discontinuation Impacts Patients

Only eight days of National Diabetes Awareness Month had passed this November when pharmaceutical company Novo Nordisk announced it would be pulling Levemir, a long-acting insulin that millions of insulin-dependent diabetic patients depend on, from the U.S. market. Read more

Patient Power Shines on US Federal and Global Stages

Patient Power Shines on US Federal and Global Stages

Advocates recently gathered in Washington, DC to attend the Senate HELP Committee Hearing entitled: The Need to Make Insulin Affordable for All Americans. The hearing, led by Chairman Senator Bernie Sanders, is the culmination of a decade of advocacy efforts by the #insulin4all community who have demanded public accountability for the global insulin price crisis. Read more